Neuroleptic malignant syndrome variant in a patient receiving donepezil and olanzapine

被引：0

作者：

Tanya C Warwick

Venkata Moningi

Prasuna Jami

Kristy Lucas

Ogochukwu Molokwu

Shalini Moningi

机构：

[1] TC Warwick is Assistant Clinical Professor of Neurology at the University of California San Francisco,

[2] Fresno,undefined

[3] CA,undefined

[4] V Moningi is Clinical Assistant Professor of Medicine,undefined

[5] K Lucas is Associate Professor of Pharmacy and Internal Medicine,undefined

[6] and S Moningi is an undergraduate student and Research Assistant at West Virginia University,undefined

[7] Charleston,undefined

[8] WV,undefined

[9] ,undefined

[10] P Jami is an Endocrinology Fellow at the University of Louisville,undefined

[11] KY,undefined

[12] O Molokwu is Assistant Clinical Professor at the School of Pharmacy,undefined

[13] University of California San Francisco,undefined

[14] CA,undefined

[15] USA.,undefined

来源：

Nature Clinical Practice Neurology | 2008年 / 4卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This Case Study describes a 78-year-old man with a pre-existing parkinsonian syndrome who experienced an adverse drug reaction following administration of an antipsychotic in combination with a cholinesterase inhibitor. The patient was diagnosed with a variant of neuroleptic malignant syndrome.

引用

页码：170 / 174

页数：4

共 50 条

[41] Olanzapine-Induced Neuroleptic Malignant Syndrome with Hypernatremia
Tutuncu, Recep
Gunay, Huseyin
Balibey, Hakan
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 22 (02): : 184 - 186
[42] Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia
Arnaout, MS
Antun, FP
Ashkar, K
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (03) : 279 - 281
[43] Olanzapine/risperidoneAtypical neuroleptic malignant syndrome: case report
Reactions Weekly, 2019, 1755 (1) : 246 - 246
[44] Olanzapine/risperidoneAtypical neuroleptic malignant syndrome: case report
Reactions Weekly, 2019, 1748 (1) : 395 - 395
[45] Neuroleptic malignant syndrome after addition of paroxetine to olanzapine
Kontaxakis, VP
Havaki-Kontaxaki, BJ
Pappa, DA
Katritsis, DE
Christodoulou, GN
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (06) : 671 - 672
[46] A case report: Olanzapine induced neuroleptic malignant syndrome
Sheokand, Niyati
Jose, Nimmi A.
Yadav, Pooja
Kapoor, Abhishek
Mahla, Vedpal
INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (09) : S545 - S546
[47] Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment
Järventausta, K
Leinonen, E
ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 (03) : 231 - 233
[48] Neuroleptic malignant syndrome in a patient with moderate intellectual disability treated with olanzapine: A case report
Piacenza, Francesco
Ong, Suet Kee
O'Brien, Patrick
Clancy, Maurice
CLINICAL CASE REPORTS, 2021, 9 (04): : 2404 - 2408
[49] Olanzapine-Induced Neuroleptic Malignant Syndrome in a Patient With Probable Dementia With Lewy Bodies
Teng, Po-Ren
Yeh, Chung-Hsin
Lin, Chun-Yi
Lai, Te-Jen
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 24 (04) : E1 - E2
[50] Neuroleptic malignant-like syndrome due to donepezil and maprotiline
Ohkoshi, N
Satoh, D
Nishi, M
Shoji, S
NEUROLOGY, 2003, 60 (06) : 1050 - 1051

← 1 2 3 4 5 →